Interleukin‐1: A master regulator of neuroinflammation
- 7 September 2004
- journal article
- review article
- Published by Wiley in Journal of Neuroscience Research
- Vol. 78 (2) , 151-156
- https://doi.org/10.1002/jnr.20266
Abstract
Interleukins 1α and 1β (IL‐1) are very potent signaling molecules that are expressed normally at low levels, but are induced rapidly in response to local or peripheral insults. IL‐1 coordinates systemic host defense responses to pathogens and to injury and not surprisingly it has similar effects within the central nervous system (CNS). Numerous reports have correlated the presence of IL‐1 in the injured or diseased brain, and its effects on neurons and nonneuronal cells in the CNS, but it is only recently that the importance of IL‐1 signaling has been recognized. This article reviews studies that demonstrate that IL‐1 is at or near the top of the hierarchical cytokine signaling cascade in the CNS that results in the activation of endogenous microglia and vascular endothelial cells to recruit peripheral leukocytes (i.e., neuroinflammation). The IL‐1 system thus provides an attractive target for therapeutic intervention to ameliorate the destructive consequences of neuroinflammation.Keywords
This publication has 76 references indexed in Scilit:
- Glutathione S-Transferase Omega 1-1 Is a Target of Cytokine Release Inhibitory Drugs and May Be Responsible for Their Effect on Interleukin-1औ Posttranslational ProcessingJournal of Biological Chemistry, 2003
- Interleukin-1 receptor type I gene-deficient bile duct-ligated mice are partially protected against endotoxinHepatology, 2002
- p38 MAPK Regulates Group IIa Phospholipase A2Expression in Interleukin-1β-stimulated Rat Neonatal CardiomyocytesPublished by Elsevier ,2001
- Interleukin-1 Receptor Type I Gene-Deficient Mice Are Less Susceptible toStaphylococcus epidermidisBiomaterial-Associated Infection than Are Wild-Type MiceInfection and Immunity, 2000
- Mice Deficient in Interleukin-1 Converting Enzyme are Resistant to Neonatal Hypoxic-Ischemic Brain DamageJournal of Cerebral Blood Flow & Metabolism, 1999
- Blood-brain barrier breach following cortical contusion in the ratJournal of Neurosurgery, 1996
- Interleukin (IL)-1β, IL-2, IL-4, IL-6 and transforming growth factor-α levels are elevated in ventricular cerebrospinal fluid in juvenile parkinsonism and Parkinson's diseaseNeuroscience Letters, 1996
- Interleukin-1 as a Pathogenetic Mediator of Ischemic Brain Damage in RatsStroke, 1995
- Interleukin-1 β and tumor necrosis factor-α synergistically stimulate nerve growth factor (NGF) release from cultured rat astrocytesNeuroscience Letters, 1990
- Expression of viral and myelin gene transcripts in a murine CNS demyelinating disease caused by a coronavirusGlia, 1989